Top Markets
Coin of the day
Eastwood Bio-Medical Canada Inc. Eastwood Bio-Medical Canada Inc.

Eastwood Bio-Medical Canada Inc.

EBM
Pozycja w akcjach #22612
Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is... Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is a company focused on the worldwide marketing and distribution of natural health products. Operating under the Eleotin brand, their offerings are available across Canada, the United States, and Asian regions. The firm's core mission is to deliver natural remedies for prevalent metabolic disorders, including issues with blood glucose regulation, hypertension, and obesity. Their extensive portfolio of licensed Eleotin products addresses diverse health requirements. For individuals experiencing spleen deficiency, appetite loss, or fatigue, Eleotin A 700 provides support. Eleotin AL88 serves as a laxative, while Eleotin Cal20 aids in the maintenance of healthy bones and teeth. Eleotin V3D is formulated for the development and upkeep of strong bones, teeth, and overall well-being. To support cardiovascular health, they offer Eleotin G2000. Eleotin H55 is designed to act as a sedative and alleviate tension, and Eleotin Zn330 is vital for tissue formation and metabolic processes. Furthermore, their product line includes Eleotin Bentley, which promotes balanced glucose levels, and Eleotin LBM, intended for hypertension relief.
Cena akcji
$1.25
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$85.95M
Zmiana (1 dzień)
-12.37%
Zmiana (1 rok)
475.37%
Kraj
CA
Handel Eastwood Bio-Medical Canada Inc. (EBM)

Kategoria

EPS dla Eastwood Bio-Medical Canada Inc. (EBM)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Eastwood Bio-Medical Canada Inc., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Eastwood Bio-Medical Canada Inc. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów